UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 245

Sortiert nach

Advances on the forefront of travellers’ diarrhoea

Journal of travel medicine, 2023-10, Vol.30 (6)

2023

Volltextzugriff (PDF)

Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report

Journal of travel medicine, 2017-04, Vol.24 (suppl_1), p.S57-S80

2017

Volltextzugriff (PDF)

The traveller and antimicrobial resistance: what’s new and where are we headed?

Journal of travel medicine, 2021-04, Vol.28 (3)

2021

Volltextzugriff (PDF)

Prevention and treatment of travellers' diarrhea

Journal of travel medicine, 2017-04, Vol.24 (suppl_1), p.S1-S1

Ericsson, Charles D

2017

Volltextzugriff (PDF)

Cefepime free minimum concentration to minimum inhibitory concentration ( f Cmin /MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia

International journal of antimicrobial agents, 2015-05, Vol.45 (5), p.541-544

2015

Volltextzugriff (PDF)

The Practice of Travel Medicine: Guidelines by the Infectious Diseases Society of America

Clinical infectious diseases, 2006-12, Vol.43 (12), p.1499-1539

2006

Volltextzugriff (PDF)

Should travel medicine practitioners prescribe antibiotics for self-treatment of travelers' diarrhea?

Journal of travel medicine, 2018, Vol.25 (1)

2018

Volltextzugriff (PDF)

Reply to JTM-17–106 Comment on ‘Guidelines for the prevention of and treatment of travellers’ diarrhoea: a graded expert panel report by Riddle et al.

Journal of travel medicine, 2017-11, Vol.24 (6)

2017

Volltextzugriff (PDF)

When should travel medicine practitioners prescribe Rifamycin SV-MXX for self-treatment of travellers’ diarrhoea?

Journal of travel medicine, 2019-05, Vol.26 (3)

2019

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea

Annals of internal medicine, 2005-05, Vol.142 (10), p.805

2005

Volltextzugriff (PDF)

Rifaximin versus Ciprofloxacin for the Treatment of Traveler's Diarrhea: A Randomized, Double-Blind Clinical Trial

Clinical infectious diseases, 2001-12, Vol.33 (11), p.1807-1815

2001

Volltextzugriff (PDF)

Azithromycin Found to Be Comparable to Levofloxacin for the Treatment of US Travelers with Acute Diarrhea Acquired in Mexico

Clinical infectious diseases, 2003-11, Vol.37 (9), p.1165-1171

2003

Volltextzugriff (PDF)

Noroviruses as a Cause of Diarrhea in Travelers to Guatemala, India, and Mexico

Journal of Clinical Microbiology, 2010-05, Vol.48 (5), p.1673-1676

2010

Volltextzugriff (PDF)

Expert Review of the Evidence Base for Prevention of Travelers' Diarrhea

Journal of travel medicine, 2009-05, Vol.16 (3), p.149-160

2009

Volltextzugriff (PDF)

Pharmacokinetic Evaluation of Single-Dose Intravenous Daptomycin in Patients with Thermal Burn Injury

Antimicrobial Agents and Chemotherapy, 2008-05, Vol.52 (5), p.1891-1893

2008

Volltextzugriff (PDF)

Stand-by antibiotics for travellers' diarrhoea: risks, benefits and research needs

Journal of travel medicine, 2018-01, Vol.25 (1)

2018

Volltextzugriff (PDF)

A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea

The American journal of tropical medicine and hygiene, 2006-06, Vol.74 (6), p.1060

2006

Volltextzugriff (PDF)

Clinical Outcomes in Patients With Gram-Negative Infections Treated With Optimized Dosing Cefepime Over Various Minimum Inhibitory Concentrations

Journal of pharmacy practice, 2018-02, Vol.31 (1), p.34-39

2018

Volltextzugriff (PDF)

Reply to 'Travellers' diarrhoea in children: a blind spot in the expert panel guidelines on prevention and treatment'

Journal of travel medicine, 2018, Vol.25 (1)

2018

Volltextzugriff (PDF)

Case report: Mycobacterium bovis orchitis post intravesical Bacillus Calmette Guerin

IDCases, 2018-01, Vol.14, p.e00465-e00465, Article e00465

2018

Volltextzugriff (PDF)

Enteroaggregative Escherichia coli as a Major Etiologic Agent in Traveler's Diarrhea in 3 Regions of the World

Clinical infectious diseases, 2001-06, Vol.32 (12), p.1706-1709

2001

Volltextzugriff (PDF)

Therapy of travelers' diarrhea with rifaximin on various continents

The American journal of gastroenterology, 2003-05, Vol.98 (5), p.1073-1078

2003

Volltextzugriff (PDF)

Travellers' diarrhoea

International journal of antimicrobial agents, 2003-02, Vol.21 (2), p.116-124

Ericsson, Charles D

2003

Volltextzugriff (PDF)

Pasteurella multocida vertebral osteomyelitis, myositis and epidural abscess in a diabetic cirrhotic patient

IDCases, 2019-01, Vol.18, p.e00630, Article e00630

2019

Volltextzugriff (PDF)

Treatment of Travelers’ Diarrhea: Randomized Trial Comparing Rifaximin, Rifaximin Plus Loperamide, and Loperamide Alone

Clinical gastroenterology and hepatology, 2007-04, Vol.5 (4), p.451-456

2007

Volltextzugriff (PDF)

1 – 25 von 245

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(203)
Mit Volltextzugriff
(192)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Advances on the forefront of travellers’ diarrhoea

Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report

The traveller and antimicrobial resistance: what’s new and where are we headed?

Prevention and treatment of travellers' diarrhea

Cefepime free minimum concentration to minimum inhibitory concentration ( f Cmin /MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia

The Practice of Travel Medicine: Guidelines by the Infectious Diseases Society of America

Should travel medicine practitioners prescribe antibiotics for self-treatment of travelers' diarrhea?

Reply to JTM-17–106 Comment on ‘Guidelines for the prevention of and treatment of travellers’ diarrhoea: a graded expert panel report by Riddle et al.

When should travel medicine practitioners prescribe Rifamycin SV-MXX for self-treatment of travellers’ diarrhoea?

A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea

Rifaximin versus Ciprofloxacin for the Treatment of Traveler's Diarrhea: A Randomized, Double-Blind Clinical Trial

Azithromycin Found to Be Comparable to Levofloxacin for the Treatment of US Travelers with Acute Diarrhea Acquired in Mexico

Noroviruses as a Cause of Diarrhea in Travelers to Guatemala, India, and Mexico

Expert Review of the Evidence Base for Prevention of Travelers' Diarrhea

Pharmacokinetic Evaluation of Single-Dose Intravenous Daptomycin in Patients with Thermal Burn Injury

Stand-by antibiotics for travellers' diarrhoea: risks, benefits and research needs

A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea

Clinical Outcomes in Patients With Gram-Negative Infections Treated With Optimized Dosing Cefepime Over Various Minimum Inhibitory Concentrations

Reply to 'Travellers' diarrhoea in children: a blind spot in the expert panel guidelines on prevention and treatment'

Case report: Mycobacterium bovis orchitis post intravesical Bacillus Calmette Guerin

Enteroaggregative Escherichia coli as a Major Etiologic Agent in Traveler's Diarrhea in 3 Regions of the World

Therapy of travelers' diarrhea with rifaximin on various continents

Travellers' diarrhoea

Pasteurella multocida vertebral osteomyelitis, myositis and epidural abscess in a diabetic cirrhotic patient

Treatment of Travelers’ Diarrhea: Randomized Trial Comparing Rifaximin, Rifaximin Plus Loperamide, and Loperamide Alone

Suchergebnisse filtern